Drug-eluting stent for brain artery narrowing
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a drug-coated stent to treat severe narrowing in brain arteries. It may help reduce the risk of stroke in people with hardened arteries in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have significant narrowing (70% or more) in a brain artery due to hardening of the arteries.
- The narrowed artery is between 2.25 and 4.00 mm in diameter.
- You have not had a major surgery in the last 30 days or plan one in the next 90 days.
- You have not had a bleeding stroke in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether an intracranial stent (a small mesh tube placed inside the brain artery) improves outcomes and safety for people with severe, symptomatic narrowing of brain arteries. It may help if symptoms continue despite antiplatelet medicine or if blood flow to the brain is poor.
This trial is testing a new stent (a small mesh tube) designed to treat wide-necked brain aneurysms. If you have this type of aneurysm, the stent helps hold coils in place to block blood flow and prevent rupture.
This trial tests whether a drug-coated stent can help people with severely narrowed brain arteries that have already caused a stroke or mini-stroke. It aims to improve blood flow and prevent future strokes.
This trial tests whether placing a stent in a severely narrowed brain artery, along with aggressive medication, can prevent another stroke better than medication alone. It is for people who had a mild stroke within the last 30 days due to a 70-99% blockage in a major brain artery.
This study records outcomes for people with significant narrowing in brain arteries who have treatment using a drug-eluting stent. It may help doctors understand how well this approach works and what risks or benefits to expect.
This trial tests a special balloon catheter coated with a drug (sirolimus) to treat narrowed arteries inside the brain caused by atherosclerosis (plaque buildup). The goal is to keep the artery open and prevent future strokes.
Hear when a new Intracranial Atherosclerotic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.